Association between Proenkephalin A and cardiovascular outcomes in ambulatory Veterans
IJC Heart & Vasculature · 2024-12 · 55 · 101557
DOI: 10.1016/j.ijcha.2024.101557 ↗Kurz gefasst
Fachartikel in der Zeitschrift IJC Heart & Vasculature, 2024-12. Verfasst von Shreya Banerjee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of California, 9500 Gilman Drive, UC, La Jolla, San Diego, CA 92037, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CSRD VA, Clinical Science Research and Development, US Department of Veterans Affairs.
Abstract (Originalsprache)
Proenkephalin (PENK) is a novel biomarker of kidney function associated with cardiovascular risk in patients with cardiovascular disease. Its association with cardiovascular outcomes in ambulatory individuals is less described. In an observational study of 199 ambulatory Veterans enrolled from April to September 2010, we assessed PENK's association with major adverse cardiac events (MACE - cardiovascular death, heart failure [HF] hospitalization, myocardial infarction [MI], or stroke) and individual outcomes of all-cause mortality, incident HF, and cardiovascular death using Cox regression. We also assessed the association of PENK with left ventricular ejection fraction (LVEF), left ventricular end-diastolic diameter (LVEDd), and left ventricular mass index (LVMi) with linear regression. The mean age was 66 ± 12 years, 99 % were men, and 76 % were White, with median follow-up of 12.7 years. Each two-fold higher PENK was associated with a 73 % higher risk of MACE in unadjusted analysis (HR 1.73; 95 % CI 1.00, 2.99; p = 0.043), though this association lost significance after adjusting for confounders (HR 1.69; 95 % CI 0.90-3.15; p = 0.098). PENK was not associated with all-cause mortality, incident HF or cardiovascular death, although risk estimates were elevated with wide confidence intervals for incident HF and cardiovascular death. PENK was not associated with LVMi or LVEDd but had a non-linear relationship with LVEF with low and high PENK associated with lower LVEF. In conclusion, PENK may be associated with a higher risk of MACE in ambulatory Veterans with diverse health statuses; however, further studies are needed. Abbreviations: PENK: Proenkephalin A; MACE: Major Adverse Cardiac Events.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, University of California, 9500 Gilman Drive, UC, La Jolla, San Diego, CA 92037, USA.
- Division of Nephrology-Hypertension, University of California, 9300 Campus Point Drive #7424 La Jolla, San Diego, CA 92037, USA.
- Division of Cardiovascular Medicine, University of California, 9300 Campus Point Drive #7424 La Jolla, San Diego, CA 92037, USA.
- Nephrology Section, Veterans Affairs San Diego Healthcare System, 3350 La Jolla Village Drive, San Diego, CA 92161, USA.
- Division of Cardiovascular Medicine, San Diego Veterans Affairs Medical Center, 3350 La Jolla Village Drive, San Diego, CA 92161, USA.
Förderung
- CSRD VA
- Clinical Science Research and Development
- US Department of Veterans Affairs
Zitieren
APA
Banerjee, S., Garimella, P. S., Hong, K. N., Bullen, A. L., Daniels, L. B., & Wettersten, N. (2024). Association between Proenkephalin A and cardiovascular outcomes in ambulatory Veterans. IJC Heart & Vasculature, 55, 101557. https://doi.org/10.1016/j.ijcha.2024.101557
Vancouver
Banerjee S, Garimella PS, Hong KN, Bullen AL, Daniels LB, Wettersten N. Association between Proenkephalin A and cardiovascular outcomes in ambulatory Veterans. IJC Heart & Vasculature. 2024;55:101557. doi:10.1016/j.ijcha.2024.101557
BibTeX
@article{Banerjee2024,
author = {Banerjee, Shreya and Garimella, Pranav S and Hong, Kimberly N and Bullen, Alexander L and Daniels, Lori B and Wettersten, Nicholas},
title = {Association between Proenkephalin A and cardiovascular outcomes in ambulatory Veterans},
journal = {IJC Heart & Vasculature},
year = {2024},
volume = {55},
pages = {101557},
doi = {10.1016/j.ijcha.2024.101557}
}
EUVIMED